Finally, it should be stressed that TP53 alterations, although important, are not the sole alterations and should be considered together with other cytogenetic abnormalities which may occur concomitantly in the single patients and may affect per se the clinical course of CLL (Figure 2). This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.